{"filing":{"accession_number":"0001654954-26-006036","cik":"0001131399","ticker":"GLAXF","company_name":"GSK plc","form":"6-K","filing_date":"2026-06-17","report_date":null,"primary_document":"a7252i.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426006036/a7252i.htm"},"events":[{"id":12460,"run_id":11033,"accession_number":"0001654954-26-006036","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"GSK announces FDA approval of Utebzi (tebipenem pivoxil), the first and only oral carbapenem antibiotic for complicated urinary tract infections. This is a material regulatory milestone and product approval event that would affect investor assessment of GSK's pipeline and commercial prospects in anti-infectives, but it does not fit the specific event categories of earnings release, M\u0026A activity, executive changes, or financial obligations. The approval represents a significant operational and strategic achievement in GSK's infectious disease portfolio.","company_name":"GSK plc","ticker":"GLAXF","filing_date":"2026-06-17","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":9316,"accession_number":"0001654954-26-006036","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"GSK announces FDA approval of Utebzi (tebipenem pivoxil), the first and only oral carbapenem antibiotic for complicated urinary tract infections. This is a material regulatory milestone and product approval event that would affect investor assessment of GSK's pipeline and commercial prospects in anti-infectives, but it does not fit the specific event categories of earnings release, M\u0026A activity, executive changes, or financial obligations. The approval represents a significant operational and strategic achievement in GSK's infectious disease portfolio.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:51:50.185969+00:00","company_name":"GSK plc","ticker":"GLAXF","filing_date":"2026-06-17"}]}